Photocure ASA

Photocure ASA (OSL:PHO) Six-month interim data presented at international conference addressing prevention of cervical cancer

Photocure ASA (OSL:PHO) Oslo, Norway, October 24th 2008.

Photocure ASA (OSL:PHO) Photocure ASA will present its third quarter 2008 report on Friday 24th of October 2008 at Shippingklubben, Haakon VIIs gate 1 (top floor), Oslo, Norway. The presentation will begin at 08.15 (CET) and representatives from the company will be Kjetil Hestdal, President & CEO and Christian Fekete, CFO.

Photocure ASA (OSL:PHO) New data confirms benefits of Hexvix cystoscopy and will form key part of documentation towards gaining regulatory approval in the USA

Photocure ASA (OSL:PHO) Oslo, Norway, 9 September 2008 - Photocure's newly developed third-generation lamp, Aktilite CL512, for use in photodynamic therapy (PDT), has received a CE mark and is now certified by Nemko, the official Notified Body within EU/EEA for medical devices.

Photocure ASA (OSL:PHO) Oslo, Norway, 8 September 2008 - Photocure is very pleased to note the recent press release by GE Healthcare (please see attachment) on the decision by the UK National Health Service (NHS) to commit to a programme designed to promote the adoption of photodynamic diagnosis (PDD) of bladder cancer as standard care.

Photocure ASA (OSL:PHO) Studies demonstrate efficacy and safety of VisonacTM and the potential for a simplified Photodynamic Therapy (PDT) procedure for treatment of moderate to severe acne.

Photocure ASA (OSL:PHO) Oslo, Norway, 21 August, 2008.

Photocure ASA (OSL:PHO) Oslo, Norway, August 15th 2008.

Photocure ASA (OSL:PHO) Photocure ASA will present its second quarter 2008 report on Friday 15th of August 2008 at Shippingklubben, Haakon VIIs gate 1 (top floor), Oslo, Norway. The presentation will begin at 08.15 (CET) and representatives from the company will be Kjetil Hestdal, President & CEO and Christian Fekete, CFO.